January 3, 2020
NuVasive employee Chris Wing, left, and Jenna Colburn demonstrate technology that trains surgeons in lateral spine surgery at NuVasive’s headquarters. The elimination of a 2.3% excise tax on medical devices benefits companies like NuVasive. Photo by Jamie Scott Lytle.
Stories this photo appears in:
HEALTH: Excise Tax Was an ACA Financing Mechanism
A recently signed federal spending bill repealed a 2.3% excise tax on medical device makers that was scheduled to resume this month, a boon to San Diego’s medtech industry.